Milestone Scientific (MLSS)
(Delayed Data from AMEX)
$0.65 USD
-0.05 (-6.61%)
Updated May 3, 2024 04:00 PM ET
After-Market: $0.66 +0.01 (1.54%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MLSS 0.65 -0.05(-6.61%)
Will MLSS be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for MLSS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MLSS
Milestone Scientific, Inc. (MLSS) Reports Q3 Loss, Lags Revenue Estimates
MLSS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MLSS
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida
Milestone Scientific commences sales of CompuFlo Epidural Disposables in Florida
Milestone Scientific: A Strong Buy on Robust Financials and Market Expansion Potential
MLSS Stock Earnings: Milestone Scientific Misses Revenue for Q4 2023
Milestone Scientific GAAP EPS of -$0.10, revenue of $9.83M